IT Solution Tracks Personalised Therapies Worldwide

US global logistics company Quick Life Science Group and TrakCel, a leading cell and gene therapy supply chain tracking and orchestration system software developer are collaborating to offer an integrated IT logistics orchestration platform that will enable global tracking of products and management of supply chain processes through a single interface.

“As one of the world’s largest providers of medical logistics services, Quick Specialized Healthcare Logistics transports every year over 80,000 human organs and tissue samples. It is now essential not only to track the transport of these products that patient’s lives depend on, but to offer every person involved in the supply of these products real-time information of the status and location of these products," said David Murphy, Executive Vice President, Quick Specialized Healthcare Logistics. “Based on the continuously growing number of therapeutic companies currently working with TrakCel and Quick, we see this partnership and the work completed as a critical step forward for the industry. It will enable companies to concentrate on developing therapies, rather than worrying about logistics.”

“We continue to see the number of sensitive, high-value materials moving through the supply chain increasing at an unprecedented rate. If not managed, the risk to patients and organisations involved in the development, manufacture and delivery of these potentially life-changing therapies will continue to increase,” said Ravi Nalliah, CEO of TrakCel. “The partnership between TrakCel and Quick will enable a significant reduction of these risks. TrakCel will continue to make sure that its partnership with Quick, offers the highest possible protection to patients awaiting much-needed therapies.”